Enesi Pharma, Sementis enter into R&D collaboration

Australia |  News | 0 Comment | 05 Nov, 2018

UK based Enesi Pharma, an innovative pharmaceutical company developing unique injectable solid dose drug-device vaccine products, and Sementis, an Australian biotechnology company developin...Read more

Flagship life sciences conference demonstrates strength and value of sector

Australia |  News | 0 Comment | 02 Nov, 2018

Singapore - The AusBiotech 2018 annual national three-day conference concluded in Brisbane after attracting over 1,000 delegates from 20 countries, the largest international delegations fro...Read more

AusBiotech, J&J announce Innovation Industry Excellence Awards

Australia |  News | 0 Comment | 01 Nov, 2018

Singapore - The AusBiotech and Johnson & Johnson Innovation Industry Excellence Awards were announced at the AusBiotech 2018 national conference in Brisbane. The Awards recognise innova...Read more

Novotech, CNS to expand CRO services to biopharma across APAC

Australia |  News | 0 Comment | 17 Oct, 2018

Singapore - Novotech the largest Asia-Pacific-based CRO has acquired Australasian specialist CRO Clinical Network Services (CNS) as part of a mutual mission to expand services to biopharma ...Read more

New technology to revolutionise healthcare

Australia |  News | 0 Comment | 17 Oct, 2018

A team at Swansea University Medical School has developed a technology that enables the secure storage and sharing of large scale data for research. This technology is all set to revolution...Read more

Resident Doctor Mario Pennisi joins Elo-Australia

Australia |  News | 0 Comment | 11 Oct, 2018

Elo Life Systems Inc. has announced that Mario G. Pennisi joined Elo Life Systems as a Resident Director of its Australian subsidiary located on the premises of the Queensland University of...Read more

Alphamab starts phase I clinical trial in Australia

Australia |  News | 0 Comment | 11 Oct, 2018

Alphamab Oncology has announced that its proprietary humanized PD-L1 - CTLA-4 bispecific antibody program, the first of its class, has recently started phase I clinical trial in Australia. ...Read more

MGC Pharma receives TGA approval to market epilepsy drug in Australia

Australia |  News | 0 Comment | 11 Oct, 2018

Australia's MGC Pharmaceuticals is pleased to announce the receipt of formal authorisation for the availability of its product CannEpil for supply in Australia through specialist prescriber...Read more

One-third unplanned pregnancies aborted in Australia, says a survey

Australia |  News | 0 Comment | 08 Oct, 2018

One in three unwanted pregnancies end in abortion, if recent research undertaken in Australia is any indication. The research, published in the Medical Journal of Australia, found that one...Read more

RMIT, Atmo sign licence agreement for gut sensors

Australia |  News | 1 Comment | 03 Oct, 2018

RMIT University in Australia has signed a commercial licence agreement with start-up Atmo Biosciences for ingestible sensors developed to measure gases in the gut in order to diagnose gut-r...Read more

Invion spin-off selects leading CRO for nadolol development

Australia |  News | 0 Comment | 27 Sep, 2018

Singapore - Chronic Airway Therapeutics (CAT), a proposed spin-off from Invion Limited, has selected leading Chinese contract research organisation R&G Pharma Studies to support the dev...Read more

Virtus appoints new non-executive director

Australia |  News | 0 Comment | 27 Sep, 2018

Singapore – Virtus Health announces the appointment of Shane Solomon to its Board as a Non-Executive Director. Solomon is a highly experienced healthcare professional having worked in...Read more

Sun Pharma announces Australian TGA approval of ILUMYA

Australia |  News | 0 Comment | 25 Sep, 2018

India's Sun Pharmaceutical recently announced that Sun Pharma has received the Australian Therapeutic Goods Administration (TGA) approval for its speciality product, ILUMYA (tildrakizumab) ...Read more

Minomic announces demerger of Glytherix

Australia |  News | 0 Comment | 25 Sep, 2018

Minomic International Ltd has announced that it received strong shareholder approval to approve the demerger of its therapeutic subsidiary, GlyTherix Ltd, at a recent extraordinary gen...Read more

Immutep collaborates with Merck, Pfizer for Efti

Australia |  News | 0 Comment | 25 Sep, 2018

Immutep Limited has announced that it has entered into a clinical trial collaboration and supply agreement with Merck KGaA, Darmstadt, Germany and Pfizer Inc., to evaluate the combination o...Read more

Daily intake of Aspirin has little effect on cardiovascular disease, says a study

Australia |  News | 0 Comment | 17 Sep, 2018

Three groundbreaking papers published in New England Journal of Medicine, led by a team of Monash University researchers in Melbourne, reveal the results from a seven-year study of the bene...Read more

Invion to spinout respiratory assets, advance clinical development in China

Australia |  News | 0 Comment | 12 Sep, 2018

Australia-based Invion recently announced plans to  spin off its two assets aimed at treating chronic airway disease into a new public unlisted company, which will develop the products...Read more

Cancer Australia releases new diagnostic data

Australia |  News | 0 Comment | 11 Sep, 2018

For the first time, national data on childhood cancer stage at diagnosis has been released, showing that a high proportion of the most common childhood cancers are diagnosed at a limited st...Read more